Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy
Author(s) -
Eric J. Velazquez,
Kerry L. Lee,
Robert H. Jones,
Hussein R. AlKhalidi,
James A. Hill,
Julio A. Panza,
Robert E. Michler,
Robert O. Bonow,
Torsten Doenst,
Mark C. Petrie,
Jae K. Oh,
Lilin She,
Vanessa Moore,
Patrice DesvigneNickens,
George Sopko,
Jean L. Rouleau
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1602001
Subject(s) - medicine , cardiology , artery , coronary artery bypass surgery , ischemic cardiomyopathy , cardiomyopathy , bypass surgery , heart failure , ejection fraction
The survival benefit of a strategy of coronary-artery bypass grafting (CABG) added to guideline-directed medical therapy, as compared with medical therapy alone, in patients with coronary artery disease, heart failure, and severe left ventricular systolic dysfunction remains unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom